東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/27 | 2,979 | 3,010 | 2,966 | 2,996 | +32 | +1.1% | 164,700 |
| 2024/03/26 | 2,900 | 2,987 | 2,899 | 2,964 | +54 | +1.9% | 165,600 |
| 2024/03/25 | 2,994 | 3,000 | 2,909 | 2,910 | -34 | -1.2% | 160,000 |
| 2024/03/22 | 2,975 | 3,015 | 2,927 | 2,944 | -34 | -1.1% | 166,200 |
| 2024/03/21 | 2,920 | 3,010 | 2,900 | 2,978 | +65 | +2.2% | 304,700 |
| 2024/03/19 | 2,858 | 2,934 | 2,842 | 2,913 | +55 | +1.9% | 188,100 |
| 2024/03/18 | 2,858 | 2,875 | 2,841 | 2,858 | +11 | +0.4% | 128,100 |
| 2024/03/15 | 2,840 | 2,856 | 2,822 | 2,847 | +3 | +0.1% | 137,300 |
| 2024/03/14 | 2,871 | 2,872 | 2,833 | 2,844 | -36 | -1.3% | 107,200 |
| 2024/03/13 | 2,875 | 2,886 | 2,832 | 2,880 | -24 | -0.8% | 154,200 |
| 2024/03/12 | 2,944 | 2,967 | 2,871 | 2,904 | +5 | +0.2% | 175,100 |
| 2024/03/11 | 2,898 | 2,956 | 2,870 | 2,899 | +41 | +1.4% | 218,400 |
| 2024/03/08 | 2,866 | 2,896 | 2,840 | 2,858 | +16 | +0.6% | 189,200 |
| 2024/03/07 | 2,828 | 2,896 | 2,811 | 2,842 | +59 | +2.1% | 203,300 |
| 2024/03/06 | 2,864 | 2,887 | 2,753 | 2,783 | -31 | -1.1% | 274,600 |
| 2024/03/05 | 2,726 | 2,912 | 2,691 | 2,814 | +64 | +2.3% | 513,300 |
| 2024/03/04 | 2,756 | 2,768 | 2,725 | 2,750 | -1 | ±0% | 155,300 |
| 2024/03/01 | 2,782 | 2,782 | 2,741 | 2,751 | -38 | -1.4% | 169,200 |
| 2024/02/29 | 2,777 | 2,834 | 2,777 | 2,789 | +8 | +0.3% | 195,400 |
| 2024/02/28 | 2,817 | 2,832 | 2,766 | 2,781 | -59 | -2.1% | 193,200 |
| 2024/02/27 | 2,870 | 2,893 | 2,833 | 2,840 | -53 | -1.8% | 194,800 |
| 2024/02/26 | 2,944 | 2,990 | 2,883 | 2,893 | -36 | -1.2% | 178,300 |
| 2024/02/22 | 3,010 | 3,015 | 2,901 | 2,929 | -70 | -2.3% | 205,400 |
| 2024/02/21 | 2,970 | 3,035 | 2,950 | 2,999 | -1 | ±0% | 188,400 |
| 2024/02/20 | 3,055 | 3,055 | 2,997 | 3,000 | -65 | -2.1% | 199,600 |
| 2024/02/19 | 2,980 | 3,075 | 2,980 | 3,065 | +102 | +3.4% | 169,400 |
| 2024/02/16 | 2,968 | 3,015 | 2,915 | 2,963 | +17 | +0.6% | 282,800 |
| 2024/02/15 | 3,230 | 3,240 | 2,917 | 2,946 | -249 | -7.8% | 501,000 |
| 2024/02/14 | 2,992 | 3,195 | 2,978 | 3,195 | +502 | +18.6% | 930,800 |
| 2024/02/13 | 2,665 | 2,696 | 2,643 | 2,693 | +56 | +2.1% | 188,600 |
| 2024/02/09 | 2,678 | 2,681 | 2,623 | 2,637 | -47 | -1.8% | 138,300 |
| 2024/02/08 | 2,664 | 2,707 | 2,647 | 2,684 | +17 | +0.6% | 151,600 |
| 2024/02/07 | 2,627 | 2,672 | 2,627 | 2,667 | +45 | +1.7% | 104,700 |
| 2024/02/06 | 2,666 | 2,666 | 2,601 | 2,622 | -39 | -1.5% | 126,400 |
| 2024/02/05 | 2,653 | 2,677 | 2,622 | 2,661 | +26 | +1% | 172,400 |
| 2024/02/02 | 2,599 | 2,642 | 2,582 | 2,635 | +15 | +0.6% | 145,500 |
| 2024/02/01 | 2,570 | 2,640 | 2,562 | 2,620 | +34 | +1.3% | 183,400 |
| 2024/01/31 | 2,551 | 2,586 | 2,546 | 2,586 | +20 | +0.8% | 125,700 |
| 2024/01/30 | 2,574 | 2,579 | 2,534 | 2,566 | -7 | -0.3% | 139,000 |
| 2024/01/29 | 2,511 | 2,579 | 2,509 | 2,573 | +81 | +3.3% | 119,200 |
| 2024/01/26 | 2,505 | 2,513 | 2,487 | 2,492 | -22 | -0.9% | 110,100 |
| 2024/01/25 | 2,552 | 2,563 | 2,505 | 2,514 | -43 | -1.7% | 115,400 |
| 2024/01/24 | 2,575 | 2,585 | 2,546 | 2,557 | -21 | -0.8% | 117,900 |
| 2024/01/23 | 2,578 | 2,615 | 2,565 | 2,578 | +4 | +0.2% | 139,500 |
| 2024/01/22 | 2,611 | 2,618 | 2,553 | 2,574 | -43 | -1.6% | 214,600 |
| 2024/01/19 | 2,637 | 2,650 | 2,571 | 2,617 | -14 | -0.5% | 251,300 |
| 2024/01/18 | 2,554 | 2,633 | 2,543 | 2,631 | +84 | +3.3% | 209,200 |
| 2024/01/17 | 2,550 | 2,601 | 2,537 | 2,547 | +43 | +1.7% | 205,500 |
| 2024/01/16 | 2,515 | 2,539 | 2,501 | 2,504 | -11 | -0.4% | 62,400 |
| 2024/01/15 | 2,470 | 2,544 | 2,470 | 2,515 | +31 | +1.2% | 119,300 |
251～
300
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
